Author Archive

Common Ground Corporate Finance introduces Capricorn Venture Partners as lead investor for a financing round in the German Company “c-LEcta”

Common Ground Corporate Finance introduces Capricorn Venture Partners as lead investor for a financing round in the German Company “c-LEcta”

c-LEcta, a German-based world-leading biotechnology company focused on enzyme engineering and applications in regulated markets like food and pharma, has closed a financing round with Leuven based Capricorn Venture Partners and the German investment company bm|t. The Capital increase was advised by CatCap, the German Globalscope alliance partner of Common Ground. Common Ground introduced Capricorn […]

Continue Reading
SYLPHAR makes add-on acquisition in the UK and welcomes two digital native brands in its portfolio, Pro Teeth Whitening and Nutravita

SYLPHAR makes add-on acquisition in the UK and welcomes two digital native brands in its portfolio, Pro Teeth Whitening and Nutravita

Deurle (Belgium), 6 September 2018 – Sylphar, the fast-growing OTC platform which teamed-up with Vendis Capital in May 2017, has acquired Pro Teeth Whitening and Nutravita, two digital native brands respectively active in teeth whitening and food supplements. Founded by two young entrepreneurs, Arash and Babak Peyami, Pro Teeth Whitening and Nutravita are two UK-based […]

Continue Reading

Quest for Growth invests more than 4 million euro in two new unquoted portfolio companies

During the summer months, Quest for Growth made two new investments in unquoted companies. In July, an investment of 2 million euro in Miracor Medical was finalized. Miracor Medical (www.miracormedical.com), located in Awans, Belgium, provides innovative solutions for the treatment of severe cardiac diseases, aiming to improve short – and long-term clinical outcomes and reduce […]

Continue Reading

SMARTSD Welcomes Smile Invest as shareholder and partner for its international expansion

The investment fund Smile Invest announces today that it will become the main shareholder of SmartSD, market leader of security solutions in the BENELUX area. The participation has to facilitate the international growth of the company, mainly in the French market. Smile Invest has about €350 million of assets under management and this is the […]

Continue Reading
Capricorn Venture Partners announces SCG as limited partner in the Capricorn Sustainable Chemistry Fund

Capricorn Venture Partners announces SCG as limited partner in the Capricorn Sustainable Chemistry Fund

Bangkok, Thailand and Leuven, Belgium: 23 August 2018 – SCG Chemicals Co., Ltd, part of the Siam Cement Public Company Limited (SCG), one of the largest integrated petrochemical companies in Thailand and a key industry leader in Asia, which offers a full range of petrochemical products, has joined the Capricorn Sustainable Chemistry Fund (CSCF) as […]

Continue Reading
Waterland adds Klinikzentrum Mühlengrund to MEDIAN

Waterland adds Klinikzentrum Mühlengrund to MEDIAN

Hamburg, 3 July 2018 – Waterland Private Equity has expanded its portfolio company MEDIAN by adding Klinikzentrum Mühlengrund in north Hesse. Mühlengrund is a modern facility for inpatient rehabilitation in the indications of orthopaedics, internal medicine/cardiology, diabetology, neurology and psychosomatics. The acquisition marks the extension of MEDIAN’s range of medical and therapeutic services and complements […]

Continue Reading
VINCI Energies acquires AVT Group, a leading provider of industrial automation and heavy load solutions

VINCI Energies acquires AVT Group, a leading provider of industrial automation and heavy load solutions

Common Ground is happy to share the successful acquisition of AVT Group by VINCI Energies, the VINCI subsidiary (Euronext Paris: DG) specializing in energy, and information and communication technology. With this acquisition, VINCI Energies further strengthens its strategic position in the Belgian market. VINCI Energies has a strong local presence and agile organisational structure with […]

Continue Reading

VIVES portfolio company iTeos Therapeutics, a spin-off of UCL and LICR, strengthened by an oversubscribed Series B fundraising of 64 million euros

  VIVES, a long-standing investor in iTeos Therapeutics, participated in the Series B €64 million fundraise. The lead and new investor, the American fund MPM Capital, will allow the UCL spin-off to develop several immune-oncology drug candidates, of which two will enter clinical testing in the coming 12 months.   Louvain-la-Neuve/Brussels, 20 June 2018 – […]

Continue Reading